Get the latest news on InnoCare Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on INCPF performance

Latest InnoCare Pharma Stock News | OTC:INCPF | Benzinga

InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

INNOCARE PHARMA LTD by INNOCARE PHARMA LTD.

Comments

InnoCare Pharma Stock News

News

Latest InnoCare Pharma Stock News | OTC:INCPF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga